Literature DB >> 10603128

Clinical outcome of Schönlein-Henoch purpura nephritis in children.

K Schärer1, R Krmar, U Querfeld, H Ruder, R Waldherr, F Schaefer.   

Abstract

We studied the long-term outcome of 64 children with biopsy-proven Schönlein-Henoch purpura (SHP) nephritis over 1-23 years of follow-up. Overall renal survival 10 years after onset was 73%. Multivariate logistic regression analysis identified initial renal insufficiency (P=0.004), nephrotic syndrome (P=0.037), and the severity of histological alterations, as defined by the proportion of glomerular crescents (P=0.051), as significant independent predictors of progressive renal failure. Four patients followed for more than 19 years showed glomerular damage after transient recovery. Eight children with crescentic nephritis associated with a rapidly progressive course and/or persistent nephrotic syndrome were treated by at least seven sessions of plasma exchange (PE) within 16 weeks of onset of purpura. During treatment serum creatinine levels dropped in each patient from a mean of 2.3 to 1.1 mg/dl, followed by a rebound increase. Repeated courses of PE in 5 patients produced comparable responses. Four patients undergoing PE reached end-stage renal disease at 1.2.-3.7 years after onset, whilst 3 finally were in preterminal renal failure (creatinine 3.2-6.1 mg/dl after 7-13.5 years), and 1 patient reached a normal glomerular filtration rate. Our experience suggests that initial renal insufficiency is the best single predictor of the further clinical course in children with SHP nephritis. Early PE appears to delay the progression in some patients with severe, rapidly progressive forms of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10603128     DOI: 10.1007/s004670050707

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  42 in total

1.  Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset.

Authors:  Outi Jauhola; Jaana Ronkainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Örmälä; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2012-02-05       Impact factor: 3.714

Review 2.  Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood.

Authors:  Marco Zaffanello; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

3.  Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schönlein purpura nephritis.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2013-07-09       Impact factor: 3.714

4.  The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis.

Authors:  Mikael Koskela; Elisa Ylinen; Elli-Maija Ukonmaanaho; Helena Autio-Harmainen; Päivi Heikkilä; Jouko Lohi; Outi Jauhola; Jaana Ronkainen; Timo Jahnukainen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

5.  Establishing hospital admission criteria of pediatric Henoch-Schonlein purpura.

Authors:  Kamal Masarweh; Yoseph Horovitz; Avi Avital; Ronen Spiegel
Journal:  Rheumatol Int       Date:  2014-02-23       Impact factor: 2.631

6.  Resolution of Henoch-Schönlein purpura nephritis after acquired IgA deficiency.

Authors:  Mototsugu Tanaka; George Seki; Kenichi Ishizawa; Junichi Hirahashi; Kenichiro Miura; Takashi Sekine; Tomonosuke Someya; Hiroshi Hataya; Michio Nagata; Toshiro Fujita
Journal:  Pediatr Nephrol       Date:  2010-06-06       Impact factor: 3.714

7.  Childhood vasculitis and plasma exchange.

Authors:  Elizabeth Wright; Michael J Dillon; Kjell Tullus
Journal:  Eur J Pediatr       Date:  2006-08-17       Impact factor: 3.183

8.  Comparison between adults and children with Henoch-Schönlein purpura nephritis.

Authors:  Shan Lu; Dong Liu; Jing Xiao; Wenming Yuan; Xiaoyang Wang; Xiaoxue Zhang; Jin Zhang; Zhangsuo Liu; Zhanzheng Zhao
Journal:  Pediatr Nephrol       Date:  2014-12-07       Impact factor: 3.714

9.  Renal biopsy 2-9 years after Henoch Schönlein purpura.

Authors:  Carmen Algoet; Willem Proesmans
Journal:  Pediatr Nephrol       Date:  2003-04-03       Impact factor: 3.714

Review 10.  Acute kidney injury in critically ill newborns: what do we know? What do we need to learn?

Authors:  David J Askenazi; Namasivayam Ambalavanan; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.